These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3488177)

  • 1. Beta-lactamase stability and in vitro activity of aztreonam, with a comparison to 9 other beta-lactam antibiotics and gentamicin.
    Friis H; Prag J; Togsverd E; Benson MW
    Chemotherapy; 1986; 32(4):329-35. PubMed ID: 3488177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-lactamase stability and in vitro activity of cefotetan; a comparison with 8 other beta-lactam antibiotics and gentamicin.
    Friis H; Prag J; Togsverd E; Benzon MW
    Acta Pathol Microbiol Immunol Scand B; 1986 Aug; 94(4):251-6. PubMed ID: 3489350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro activity and beta-lactamase stability of carumonam.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Delhi Metallo-β-Lactamase 1 Catalyzes Avibactam and Aztreonam Hydrolysis.
    Lohans CT; Brem J; Schofield CJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971873
    [No Abstract]   [Full Text] [Related]  

  • 5. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Brogden RN; Heel RC
    Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
    Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
    Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.
    Poirel L; Brinas L; Fortineau N; Nordmann P
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3593-7. PubMed ID: 16048994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams].
    Labia R; Morand A; Pitton JS; Philippin JL; Fournier P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):796-9. PubMed ID: 3309817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity and beta-lactamase stability of a monobactam, SQ 26,917, compared with those of aztreonam and other agents.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1983 Aug; 24(2):227-32. PubMed ID: 6605715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Delhi metallo-β-lactamase (NDM-1): an update.
    Shakil S; Azhar EI; Tabrez S; Kamal MA; Jabir NR; Abuzenadah AM; Damanhouri GA; Alam Q
    J Chemother; 2011 Oct; 23(5):263-5. PubMed ID: 22005056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sch 34343, in-vitro antibacterial activity and beta-lactamase stability.
    Stobberingh EE; Houben AW; van Boven CP
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():73-83. PubMed ID: 3875605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam.
    Bert F; Bialek-Davenet S; Leflon-Guibout V; Noussair L; Nicolas-Chanoine MH
    Med Mal Infect; 2014 Feb; 44(2):76-8. PubMed ID: 24525113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of aztreonam as a substrate, inhibitor and inducer for beta-lactamases.
    Sakurai Y; Yoshida Y; Saitoh K; Nemoto M; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1990 Apr; 43(4):403-10. PubMed ID: 2112533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A; Mattina R; Cocuzza CE
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
    Bakhtiar M; Selwyn S
    Drugs Exp Clin Res; 1989; 15(10):477-82. PubMed ID: 2698794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of aztreonam--a new monocyclic beta-lactam antibiotic.
    Friis H
    Dan Med Bull; 1985 Jun; 32(3):196-8. PubMed ID: 4040456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aztreonam: the first monobactam.
    Sykes RB; Bonner DP
    Am J Med; 1985 Feb; 78(2A):2-10. PubMed ID: 3871589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.